期刊
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
卷 71, 期 23, 页码 2691-2701出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2018.04.030
关键词
atrial fibrillation; fitness; cardiovascular disease; mHealth; mobile health; physical activity; prevention
资金
- Amazon
- AstraZeneca
- Bristol-Myers Squibb
- Medtronic
- AHA
- Apple
- Janssen
- Cardiva Medical
- Boehringer Ingelheim
- Abbott
- iRhythm
- Precision Health
- Amgen
- Bayer
- Gilead
- Merck
- MyoKardia
- Medicines Company
- CSL Limited
- GlaxoSmithKline
- Novartis
- Portola
- Sanofi
The growing recognition that health takes place outside of the hospital and clinic, plus recent advances in mobile and wearable devices, have propelled the field of mobile health (mHealth). Cardiovascular disease and prevention are major opportunities for mHealth, as mobile devices can monitor key physiological signals (e.g., physical activity, heart rate and rhythm) for promoting healthy behaviors, detecting disease, and aid in ongoing care. In this review, the authors provide an update on cardiovascular mHealth by highlighting recent progress and challenges with mobile and wearable devices for assessing and promoting physical activity and fitness, and for monitoring heart rate and rhythm for the detection and management of atrial fibrillation. (C) 2018 by the American College of Cardiology Foundation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据